|
|
||||||||
From the First Department of Medicine (Drs. Miyajima, Kono, Takahashi, and Sugimoto), Hamamatsu University School of Medicine; Department of Neurology (Dr. Sakamoto), Hamamatsu Medical Center, Hamamatsu; and Department of Neurology (Dr. Sakai), Yaizu General Hospital, Yaizu, Japan.
Address correspondence and reprint requests to Dr. Hiroaki Miyajima, The First Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu 431-3192, Japan; e-mail: miyajima{at}hama-med.ac.jp
Background: Aceruloplasminemia, an autosomal recessive disorder that affects human iron metabolism, is caused by mutation of the ceruloplasmin gene. Heterozygous individuals with a partial ceruloplasmin deficiency may have normal iron metabolism and no clinical symptoms.
Methods: The authors clinically characterized three Japanese patients from two families who had cerebellar ataxia with hypoceruloplasminemia from the fourth decade of life. Genetic analysis, restriction fragment length polymorphism analysis, and a pathologic study were performed.
Results: All three patients presented with cerebellar dysfunction that included relatively nondisabling gait ataxia and dysarthria, as well as hyperreflexia. Brain and abdomen MRI showed cerebellar atrophy and no low-signal intensities in the basal ganglia, thalamus, and liver. Direct mutational analysis excluded SCA-1, SCA-2, SCA-3, SCA-6, SCA-7, SCA-8, SCA-12, and DRPLA. The patients partially lacked serum ceruloplasmin, and the protein concentrations and ferroxidase activities ranged from 36% to 41% of the control values; moreover, they were heterozygous for a nonsense mutation of the ceruloplasmin gene (Trp858ter). Serum iron concentration and transferrin saturation were normal. At autopsy, pathologic and biochemical examinations showed marked loss of Purkinje cells, a large iron deposition in the cerebellum, and small depositions in the basal ganglia, thalamus, and liver.
Conclusion: Cerebellar ataxia reflects the site of iron deposition. Being heterozygous for mutation of the ceruloplasmin gene may result in cerebellar ataxia.
This article has been cited by other articles:
![]() |
A. Henri-Bhargava, C. Melmed, R. Glikstein, and H. M. Schipper NEUROLOGIC IMPAIRMENT DUE TO VITAMIN E AND COPPER DEFICIENCIES IN CELIAC DISEASE Neurology, September 9, 2008; 71(11): 860 - 861. [Full Text] [PDF] |
||||
![]() |
M. Grisoli, A. Piperno, L. Chiapparini, R. Mariani, and M. Savoiardo MR Imaging of Cerebral Cortical Involvement in Aceruloplasminemia AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 657 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Mariani, C Arosio, S Pelucchi, M Grisoli, A Piga, P Trombini, and A Piperno Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation Gut, May 1, 2004; 53(5): 756 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Haemers, S Kono, S Goldman, J D Gitlin, and M Pandolfo Clinical, molecular, and PET study of a case of aceruloplasminaemia presenting with focal cranial dyskinesia J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 334 - 337. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |